Methods for treating depression using NCAM peptide mimetics

US9234242B2 · kind B2 · utility

Assignee

• Board of Trustees of the Leland Stanford Junior University · US

Inventors

• Huda Akil · Ann Arbor, US
• Stanley Watson · Ann Arbor, US
• Cortney Turner · Willis, US
• William E. Bunny · Laguna Hills, US
• Edward G. Jones · Winters, US
• Richard M. Myers · Huntsville, US
• Alan F. Schatzberg · Los Altos, US

Key dates

• Filing date: Mar 27, 2012
• Grant date: Jan 12, 2016
• Expiry date: Mar 27, 2032

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N2800/304
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to the treatment and diagnosis of mood disorders, including bipolar disorder, major depression disorder and schizophrenia. The invention provides novel diagnostic markers and assays, as well as research tools for the development and discovery of agents and compounds which are useful for treating patients who suffer from mental illness.